Brought to you by:
Data shows disease severity drives ALI outcomes more than treatment choice
A large retrospective study of patients with acute limb ischemia (ALI) found that early outcomes including limb salvage, survival and amputation-free survival are equivalent between open surgery-first and endovascular-first revascularization strategies. The research determined that outcomes were driven primarily by…
RESCUE II results on Thrombolex’s Bashir endovascular catheter for PE published
Thrombolex recently announced the publication of RESCUE-II study results in JACC: Advances. The RESCUE-II study was a single-centre, prospective study evaluating the safety and feasibility of on-the-table (OTT) pharmacomechanical lysis (PML) without postprocedural infusion when treating patients with acute intermediate-risk…
BIO-OSCAR SOC trial examines standard of care in PAD treatment
Biotronik today announced that it has concluded the BIO-OSCAR SOC study evaluating the baseline against which to measure the Oscar multifunctional catheter in treating complex peripheral arterial disease (PAD). The outcomes were presented at the Paris Vascular Insights (PVI) course 2024…
Microbot Medical announces FDA submission for commercialization of Liberty endovascular robotic system
Microbot Medical recently announced that it has submitted a 510(k) premarket notification to the Food and Drug Administration (FDA) for its Liberty endovascular robotic system. A press release details that Liberty is the world’s first single-use, fully disposable robotic system…
Surmodics announces early results from PROWL registry of Pounce thrombectomy system
Surmodics has announced that early results of a subset of 60 real-world acute, subacute, and chronic limb ischaemia patients from its PROWL registry study were presented by Dean Ferrera (Powers Health, Munster, USA) at TCT 2024 (27–30 October, Washington, DC,…
Cook Medical creates custom-made aortic device for fenestrated FET procedure
Cook Medical this week announced that it has created a custom-made device for the frozen elephant trunk (FET) aortic procedure. A press release details that, earlier this year, cardiothoracic surgeon François Dagenais, MD, from the Quebec Heart and Lung Institute…
Philips announces FDA approval for enhanced LumiGuide guidewire, marks 1000th patient treated with 3D guidance technology
Royal Philips today announced the introduction of the 160cm Food and Drug Administration (FDA)-approved version of its LumiGuide endovascular navigation wire. This enhanced LumiGuide guidewire, which utilises the company’s Fiber Optic RealShape (FORS) technology, was used for the first time…
Centerline Biomedical receives FDA 510(k) clearance for new IOPS Viewpoint catheter
Centerline Biomedical recently announced that its Intra-Operative Positioning System (IOPS) Viewpoint catheter has received Food and Drug Administration (FDA) 510(k) clearance. The Viewpoint catheter is the most recent addition to the company’s patented IOPS portfolio. A press release details that Viewpoint—a…
Endovascular CFA treatment associated with increased rate of long-term CFA-specific reintervention, study finds
A recent study suggests that endovascular treatment of the common femoral artery (CFA) is associated with an increased rate of long-term CFA-specific reintervention, regardless of indication. Nicholas Wells, a medical student at Yale School of Medicine in New Haven, USA,…
Vascular surgery trainees face the future armed similarly with both open and endovascular skills
The BEST-CLI trial underscores the importance of ensuring trainee competence in open peripheral revascularization as well as endovascular treatment. Indeed, the trial results have called for a reshift in focus to ensure trainees have much needed open skills. That’s because,…